Functional mechanism and clinical implications of LINC00339 in delayed fracture healing.


Journal

Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112

Informations de publication

Date de publication:
27 Aug 2024
Historique:
received: 19 07 2024
accepted: 16 08 2024
medline: 28 8 2024
pubmed: 28 8 2024
entrez: 27 8 2024
Statut: epublish

Résumé

Delayed fracture healing is a common complication of fractures that significantly impacts human health. This study aimed to explore the role of LINC00339 (lncRNA) in delayed fracture healing to provide new directions for its treatment. This study included 82 patients with fractures healing in a normal manner and 90 patients experiencing delayed fracture healing. Levels of LINC00339, miR-16-5p, and osteogenic marker-related mRNAs were measured using RT-qPCR. The predictive potential of LINC00339 for delayed fracture healing was validated using ROC curve analysis. The interaction between LINC00339 and miR-16-5p was validated using dual-luciferase reporter assays and RIP experiments. CCK-8 was used to assess cell proliferation, and apoptosis rates were measured by flow cytometry. LINC00339 was significantly upregulated in delayed fracture healing patients and exhibited strong predictive ability for this condition. Overexpression of LINC00339 inhibited osteoblast proliferation, promoted apoptosis, and reduced mRNA levels of osteogenic markers (P < 0.05). miR-16-5p was recognized as a target mRNA of LINC00339, with LINC00339 exerting negative regulation on miR-16-5p, while overexpression of miR-16-5p mitigated the inhibitory effects of LINC00339 on fracture healing (P < 0.05). This research indicated that LINC00339 may serve as a diagnostic marker for delayed fracture healing and revealed the function of the LINC00339/miR-16-5p axis on fracture healing by regulating osteoblasts.

Identifiants

pubmed: 39192334
doi: 10.1186/s13018-024-04998-0
pii: 10.1186/s13018-024-04998-0
doi:

Substances chimiques

RNA, Long Noncoding 0
MicroRNAs 0
MIRN16 microRNA, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

511

Informations de copyright

© 2024. The Author(s).

Références

Melvin JS, Mehta S. Patellar fractures in adults. J Am Acad Orthop Surg. 2011;19(4):198–207.
doi: 10.5435/00124635-201104000-00004 pubmed: 21464213
Argote A, Mora-Hernandez O, Milena Aponte L, Barrera-Chaparro DI, Munoz-Ruiz LM, Giraldo-Mordecay L, et al. Cardiovascular Risk factors and carotid intima-media thickness in a Colombian Population with Psoriasis. Actas Dermosifiliogr. 2017;108(8):738–45.
doi: 10.1016/j.ad.2017.04.015 pubmed: 28662815
Dhamangaonkar AC, Patankar HS. Salvage of delayed union of a phalangeal fracture with a hairpin wire. Hand Surg. 2013;18(3):431–3.
doi: 10.1142/S0218810413720325 pubmed: 24156594
Daughaday WH, Hall K, Raben MS, Salmon WD Jr., van den Brande JL, van Wyk JJ. Somatomedin: proposed designation for sulphation factor. Nature. 1972;235(5333):107.
doi: 10.1038/235107a0 pubmed: 4550398
Jha S, Blau JE, Bhattacharyya T. Normal and delayed Fracture Healing: Symphony and Cacophony. Horm Metab Res. 2016;48(11):779–84.
doi: 10.1055/s-0042-117636 pubmed: 27728927
Cheng Z, Li A, Tu CL, Maria CS, Szeto N, Herberger A, et al. Calcium-sensing receptors in chondrocytes and osteoblasts are required for Callus Maturation and Fracture Healing in mice. J Bone Min Res. 2020;35(1):143–54.
doi: 10.1002/jbmr.3864
Committee of Accelerated Rehabilitation after Osteoporotic Fractures of China Association of Rehabilitation, Technology T, Promotion, Bone, Joint Group of Chinese Society of O, Bone Mineral R Osteoporosis Working Committee of Chinese Association of Orthopedic S. [Chinese expert consensus on treatment of osteoporotic fractures with teriparatide (2024 edition)]. Zhonghua Yi Xue Za Zhi. 2024;104(17):1456–65.
Szczesny G. Fracture Healing and its disturbances. A literature review. Ortop Traumatol Rehabil. 2015;17(5):437–54.
doi: 10.5604/15093492.1186809 pubmed: 26751744
Yin Y, He Q, He J, Feng Y, Xu Y. Inhibition of LINC00958 hinders the progression of osteoarthritis through regulation of the miR-214-3p/FOXM1 axis. J Orthop Surg Res. 2024;19(1):66.
doi: 10.1186/s13018-024-04545-x pubmed: 38218927 pmcid: 10788018
Zhou Z, Chen J, Huang Y, Liu D, Chen S, Qin S. Long noncoding RNA GAS5: a new factor involved in Bone diseases. Front Cell Dev Biol. 2021; 9807419.
Guo X, Zhang J, Han X, Wang G. LncRNA SNHG1 delayed Fracture Healing via modulating miR-181a-5p/PTEN Axis. J Invest Surg. 2022;35(6):1304–12.
doi: 10.1080/08941939.2022.2048926 pubmed: 35263556
Yu C, Chen B, Su H, Yang Y. Long non-coding RNA MIAT serves as a biomarker of fragility fracture and promotes fracture healing. J Orthop Surg Res. 2024;19(1):343.
doi: 10.1186/s13018-024-04824-7 pubmed: 38849896 pmcid: 11162066
Chen S, Ma H, Li M, Jia Z, Chen X, Bu N. Long noncoding RNA NORAD promotes fracture healing through interacting with osteoblast differentiation via Targeting miR-26a. Biomed Res Int. 2023; 20239950037.
Wu Z, Zhang S, Guo W, He Y. LINC00339: an emerging major player in cancer and metabolic diseases. Biomed Pharmacother. 2022; 149112788.
Guo J, Cai H, Liu X, Zheng J, Liu Y, Gong W et al. Long non-coding RNA LINC00339 stimulates glioma vasculogenic mimicry formation by regulating the miR-539-5p/TWIST1/MMPs Axis. Mol Ther Nucleic Acids. 2018; 10170–86.
Zhang Y, Zhang Y, Yang K, Guo W, Ma X, Ma X, et al. MALAT1 knockdown promoted cell viability and migration of LPS-treated MG-63 cells via sponging miR-212. Genes Genomics. 2021;43(5):523–31.
doi: 10.1007/s13258-021-01038-7 pubmed: 33725277
Chen XF, Zhu DL, Yang M, Hu WX, Duan YY, Lu BJ, et al. An osteoporosis risk SNP at 1p36.12 acts as an allele-specific enhancer to modulate LINC00339 expression via Long-Range Loop formation. Am J Hum Genet. 2018;102(5):776–93.
doi: 10.1016/j.ajhg.2018.03.001 pubmed: 29706346 pmcid: 5986728
Zhang M, Xu F, Cao J, Dou Q, Wang J, Wang J et al. Research advances of nanomaterials for the acceleration of fracture healing. Bioact Mater. 2024; 31368–94.
Saleh K, Hak D. Nierengarten MJMOCu. Socioeconomic burden of traumatic tibial fractures: non union or delayed union. 2001; 1–22.
Antonova E, Le TK, Burge R, Mershon J. Tibia shaft fractures: costly burden of nonunions. BMC Musculoskelet Disord. 2013; 1442.
Dong Z, Hu B, Wang S, Wang M, Sun S, Liu X, et al. LncRNA MAGI2-AS3 promotes fracture healing through downregulation of miR-223-3p. J Orthop Surg Res. 2024;19(1):370.
doi: 10.1186/s13018-024-04850-5 pubmed: 38907263 pmcid: 11193218
Jiang M, Liu R, Liu L, Kot A, Liu X, Xiao W, et al. Identification of osteogenic progenitor cell-targeted peptides that augment bone formation. Nat Commun. 2020;11(1):4278.
doi: 10.1038/s41467-020-17417-9 pubmed: 32855388 pmcid: 7453024
Komatsu DE, Duque E, Hadjiargyrou M. MicroRNAs and fracture healing: pre-clinical studies. Bone. 2021; 143115758.
Nugent M. MicroRNAs and Fracture Healing. Calcif Tissue Int. 2017;101(4):355–61.
doi: 10.1007/s00223-017-0296-x pubmed: 28589206
Yu T, You X, Zhou H, He W, Li Z, Li B, et al. MiR-16-5p regulates postmenopausal osteoporosis by directly targeting VEGFA. Aging. 2020;12(10):9500–14.
doi: 10.18632/aging.103223 pubmed: 32427128 pmcid: 7288956
Sun Y, Xiong Y, Yan C, Chen L, Chen D, Mi B, et al. Downregulation of microRNA-16-5p accelerates fracture healing by promoting proliferation and inhibiting apoptosis of osteoblasts in patients with traumatic brain injury. Am J Transl Res. 2019;11(8):4746–60.
pubmed: 31497196 pmcid: 6731405
Sang S, Zhang Z, Qin S, Li C, Dong Y. MicroRNA-16-5p inhibits Osteoclastogenesis in Giant Cell Tumor of Bone. Biomed Res Int. 2017; 20173173547.
Duan J, Li H, Wang C, Yao J, Jin Y, Zhao J et al. BMSC-derived extracellular vesicles promoted osteogenesis via Axin2 inhibition by delivering MiR-16-5p. Int Immunopharmacol. 2023; 120110319.

Auteurs

Yuntao Li (Y)

Department of Integrated Traditional Chinese and Western Medicine, Tianjin Hospital, Tianjin, 300211, China.

Ya Sun (Y)

Department of Breast Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.

Ke Ma (K)

College of Medical Technology, Zibo Vocational Institute, Zibo, 255000, China.

Shengqian Wang (S)

Department of Emergency, Zibo Combined Traditional Chinese and Western Medicine Hospital, Zibo, 255000, China.

Zhibiao Wang (Z)

Department of Orthopedics, Rizhao Central Hospital, No. 66, Wanghai Road, Donggang District, Rizhao City, Shandong Province, 276800, China. wangzhibo53@163.com.

Lina Huang (L)

Department of Rehabilitation Medicine, The Affiliated Hospital of Youjiang Medical University for Nationalities, No.18, Zhongshan 2nd Road, Youjiang District, Baise City, Guangxi, 533000, China. 14736050709@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH